Replies to post #1886 on Lexington Biosciences Inc. (LXGTF)

[StockBro75]

This link says the average clearance time for a "cardiovascular device" is 179 days in the FDA 510K track. Its on page 8. https://www.emergogroup.com/sites/default/files/emergo-fda-510k-data-analysis-2017.pdf

[StockBro75]

Looks like LXGTF itself estimates 2019 as timeframe for being done with clinical trials, FDA clearance, secured and ready to market. Page 24 of the corporate presentation: https://lexingtonbiosciences.com/wp-content/uploads/2017/10/Lexington-Website-Presentation.pdf